Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis

S E Rier1, A K Parsons, J L Becker

  • 1Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa 33606.

Fertility and Sterility
|February 1, 1994
PubMed

Insights

Interleukin-6 (IL-6) is present in peritoneal fluid in endometriosis patients. Peritoneal leukocytes show altered IL-6 production based on disease severity, suggesting a role in endometriosis pathophysiology.

Area of Science:

  • Reproductive immunology
  • Gynecologic pathology

Background:

  • Interleukin-6 (IL-6) is a key cytokine implicated in inflammatory processes.
  • Its role in the pathophysiology of endometriosis, a chronic inflammatory condition, requires further elucidation.

Purpose of the Study:

  • To investigate the in vitro production of IL-6 by peritoneal leukocytes.
  • To determine the presence of IL-6 in peritoneal fluid (PF) in vivo.

Main Methods:

  • Peritoneal leukocytes were obtained from women undergoing laparoscopy for pain, infertility, or tubal ligation.
  • Leukocyte IL-6 production was assessed spontaneously and after stimulation.
  • IL-6 levels in peritoneal fluid were quantified.

Main Results:

  • Peritoneal leukocytes from women with mild endometriosis or adhesions produced higher spontaneous levels of IL-6 compared to controls and severe endometriosis.
  • Leukocytes from all endometriosis groups were unresponsive to endotoxin stimulation.
  • Bioactive IL-6 was detected in the peritoneal fluid of all study groups.

Conclusions:

  • IL-6 is present in the peritoneal fluid of women with and without endometriosis.
  • Peritoneal leukocyte IL-6 production varies with endometriosis stage.
  • Altered IL-6 production by leukocytes may contribute to endometriosis development and progression.
Abstract